HPS Pharmacies wish to advise that GlaxoSmithKline Australia, in consultation with the Therapeutic Goods Administration (TGA) have given notice of a drug recall of Bactroban® Cream 15g and Bactroban® Nasal Ointment 3g.
The affected batches are:
|Bactroban® Cream||C685907||11145||January 2016|
|Bactroban® Cream||C692806||11145||February 2016|
|Bactroban® Cream||C698025||11145||March 2016|
|Bactroban® Cream||C697657||11145||March 2016|
|Bactroban® Cream||C702376||11145||April 2016|
|Bactroban® Nasal Ointment||C684916||11199||July 2017|
|Bactroban® Nasal Ointment||C697795||11199||September 2017|
|Bactroban® Nasal Ointment||C702770||11199||October 2017|
This recall is a precautionary measure in response to contamination of the mupirocin calcium active ingredient with sub-visible particulate matter.
Please inspect your stocks and quarantine all products from the batches listed above for return to your supplier for a refund.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or GlaxoSmithKline Australia on 1800 028 533.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.